Conditions associated with marine lipid-induced milk fat depression in sheep cause shifts in the in vitro ruminal metabolism of 1-13C oleic acid
Shifts in ruminal oleic acid (OA) metabolism have received little research attention but recent studies have suggested their association with marine lipid-induced milk fat depression (MFD) in ewes and cows. Measurement of specific products of OA within the complex mixture of digesta lipids is howeve...
| Autores: | , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2018 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/171859 |
| Acceso en línea: | http://hdl.handle.net/10261/171859 |
| Access Level: | acceso abierto |
| Palabra clave: | Ewe Lipid metabolism Oxigenated fatty acid Rumen Stable isotope Trans fatty acid |
| Sumario: | Shifts in ruminal oleic acid (OA) metabolism have received little research attention but recent studies have suggested their association with marine lipid-induced milk fat depression (MFD) in ewes and cows. Measurement of specific products of OA within the complex mixture of digesta lipids is however challenging. Therefore, this in vitro trial combined the isotopic labelling technique with the use of rumen inoculum from cannulated sheep fed a diet supplemented or not with 2% of fish oil (which has been demonstrated to cause MFD in dairy ruminants) to characterize the metabolism of OA in response to ruminal alterations associated with MFD. The products of 13C-OA after 24 h of incubation were analysed by gas chromatography-combustion isotope ratio mass spectrometry (GC-C-IRMS). Numerous 13C-labeled 18:1 intermediates and oxygenated FA were detected and no elongation or desaturation of 13OA occurred. Diet supplementation with fish oil (i.e., MFD conditions) resulted in no unique metabolites of 13OA but in relevant changes in the relative contribution of specific metabolic pathways. The inhibition of 18:0 saturation caused by this treatment appeared largely attributable to increased oxygenated FA proportion, in particular the candidate milk fat inhibitor 10-oxo-18:0, and warrants further research on the association between MFD and oxygenated FA. Changes in the concentration of 13C-labeled trans 18:1 intermediates but not in cis 18:1, were also observed. |
|---|